Insmed to Present at Three November Conferences
06 Novembre 2018 - 2:30PM
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical
company on a mission to transform the lives of patients with
serious and rare diseases, today announced that management
will participate in the following investor conferences:
- The Credit Suisse 27th Annual Healthcare Conference in
Scottsdale, AZ on Tuesday, November 13, 2018 at 10:20 a.m.
MST.
- The Stifel 2018 Healthcare Conference in New York, NY on
Wednesday, November 14, 2018 at 12:30 p.m. ET.
- The Evercore ISI HealthconX Conference in Boston, MA on
Wednesday, November 28, 2018 at 11:20 a.m. ET.
These presentations will be webcast live and can be accessed by
visiting the investor relations section of the company's website
at www.insmed.com. The webcasts will be archived for a period
of 90 days following the conclusion of each live event.
About InsmedInsmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed’s first commercial
product is ARIKAYCE® (amikacin liposome inhalation suspension),
which is approved in the United States for the treatment of
Mycobacterium avium complex (MAC) lung disease as part of a
combination antibacterial drug regimen for adult patients with
limited or no alternative treatment options. MAC lung disease is a
rare and often chronic infection that can cause irreversible lung
damage and can be fatal. Insmed's earlier-stage clinical pipeline
includes INS1007, a novel oral reversible inhibitor of dipeptidyl
peptidase 1 with therapeutic potential in non-cystic fibrosis
bronchiectasis and other inflammatory diseases, and INS1009, an
inhaled formulation of a treprostinil prodrug that may offer a
differentiated product profile for rare pulmonary disorders,
including pulmonary arterial hypertension. For more information,
visit www.insmed.com.
Contact:Blaine Davis Insmed Incorporated (908) 947-2841
blaine.davis@insmed.com
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024